A Pilot Bioequivalence Study of Pomalidomide

NCT03424928 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: Pomalidomide 4 MG Oral Capsule
DRUG: Pomalidomide 4 MG Oral Capsule-Pomalyst

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.

Collaborators

[object Object]